Table 3.
Characteristics of lung cancer patients with severe AKI
| No. (%) (n=68) | |
|---|---|
| Pathology | |
| Adenocarcinoma | 33 (48.5) |
| Squamous cell carcinoma | 15 (22.0) |
| Small cell carcinoma | 11 (16.2) |
| Others | 9 (13.2) |
| Cause of AKI | |
| Septic | 30 (44.1) |
| Ischemic | 15 (22.1) |
| Postoperative | 8 (11.8) |
| Toxica) | 6 (8.8) |
| Cardiorenal | 2 (2.9) |
| Others | 7 (10.3) |
| Renal replacement therapy | 3 (4.4) |
| Admission to intensive care unit | 11 (16.2) |
| Improvement of AKI | 63 (92.6) |
| Death | 10 (14.7) |
AKI, acute kidney injury.
a)
Contrast-induced nephropathy (2), platinum (2), gemcitabine (1), vancomycin (2).